# OneMain Holdings, Inc.: financial statements, quarterly

OMF · NYSE · CIK 1584207 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/omf.md) · [Financials](/companies/omf/financials.md) · [Filings](/companies/omf/filings.md) · [Insiders](/companies/omf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/omf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $m | [35.0](/filings/0001584207-24-000021.md) | [52.0](/filings/0001584207-24-000028.md) | [56.0 d](/filings/0001584207-26-000008.md) | [49.0](/filings/0001584207-25-000025.md) | [21.0](/filings/0001584207-25-000038.md) | [50.0](/filings/0001584207-25-000046.md) | [38.0 d](/filings/0001584207-26-000008.md) | [62.0](/filings/0001584207-26-000020.md) | [47.0](/filings/0001584207-25-000038.md) | [64.0](/filings/0001584207-25-000046.md) | [45.0 d](/filings/0001584207-26-000008.md) | [70.0](/filings/0001584207-26-000020.md) |
| Net income | $m | [103](/filings/0001584207-24-000021.md) | [194](/filings/0001584207-24-000028.md) | [165 d](/filings/0001584207-26-000008.md) | [155](/filings/0001584207-25-000025.md) | [71.0](/filings/0001584207-25-000038.md) | [157](/filings/0001584207-25-000046.md) | [126 d](/filings/0001584207-26-000008.md) | [213](/filings/0001584207-26-000020.md) | [167](/filings/0001584207-25-000038.md) | [199](/filings/0001584207-25-000046.md) | [204 d](/filings/0001584207-26-000008.md) | [226](/filings/0001584207-26-000020.md) |
| Diluted EPS | $ per share | [0.85](/filings/0001584207-24-000021.md) | [1.61](/filings/0001584207-24-000028.md) | not reported | [1.29](/filings/0001584207-25-000025.md) | [0.59](/filings/0001584207-25-000038.md) | [1.31](/filings/0001584207-25-000046.md) | not reported | [1.78](/filings/0001584207-26-000020.md) | [1.40](/filings/0001584207-25-000038.md) | [1.67](/filings/0001584207-25-000046.md) | not reported | [1.93](/filings/0001584207-26-000020.md) |
| Basic EPS | $ per share | [0.85](/filings/0001584207-24-000021.md) | [1.61](/filings/0001584207-24-000028.md) | not reported | [1.29](/filings/0001584207-25-000025.md) | [0.59](/filings/0001584207-25-000038.md) | [1.32](/filings/0001584207-25-000046.md) | not reported | [1.79](/filings/0001584207-26-000020.md) | [1.40](/filings/0001584207-25-000038.md) | [1.67](/filings/0001584207-25-000046.md) | not reported | [1.93](/filings/0001584207-26-000020.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.0](/filings/0001584207-24-000021.md) | [1.2](/filings/0001584207-24-000028.md) | [1.0](/filings/0001584207-26-000008.md) | [0.8](/filings/0001584207-25-000025.md) | [0.7](/filings/0001584207-25-000038.md) | [0.6](/filings/0001584207-25-000046.md) | [0.5](/filings/0001584207-26-000008.md) | [0.6](/filings/0001584207-26-000020.md) | [0.8](/filings/0001584207-25-000038.md) | [0.7](/filings/0001584207-25-000046.md) | [0.9](/filings/0001584207-26-000020.md) | [0.8](/filings/0001584207-26-000020.md) |
| Total assets | $bn | [23.5](/filings/0001584207-24-000021.md) | [24.1](/filings/0001584207-24-000028.md) | [24.3](/filings/0001584207-26-000008.md) | [23.9](/filings/0001584207-25-000025.md) | [25.1](/filings/0001584207-25-000038.md) | [25.6](/filings/0001584207-25-000046.md) | [25.9](/filings/0001584207-26-000008.md) | [26.0](/filings/0001584207-26-000020.md) | [26.6](/filings/0001584207-25-000038.md) | [27.0](/filings/0001584207-25-000046.md) | [27.4](/filings/0001584207-26-000020.md) | [27.0](/filings/0001584207-26-000020.md) |
| Total liabilities | $bn | [20.5](/filings/0001584207-23-000023.md) | [21.0](/filings/0001584207-23-000028.md) | [21.1](/filings/0001584207-25-000006.md) | [20.7](/filings/0001584207-24-000014.md) | [21.9](/filings/0001584207-24-000021.md) | [22.4](/filings/0001584207-24-000028.md) | [22.7](/filings/0001584207-26-000008.md) | [22.7](/filings/0001584207-25-000025.md) | [23.3](/filings/0001584207-25-000038.md) | [23.6](/filings/0001584207-25-000046.md) | [24.0](/filings/0001584207-26-000020.md) | [23.6](/filings/0001584207-26-000020.md) |
| Long-term debt | $bn | [19.2](/filings/0001584207-23-000023.md) | [19.9](/filings/0001584207-23-000028.md) | [19.8](/filings/0001584207-25-000006.md) | [19.5](/filings/0001584207-24-000014.md) | [20.7](/filings/0001584207-24-000021.md) | [21.1](/filings/0001584207-24-000028.md) | [21.4](/filings/0001584207-26-000008.md) | [21.5](/filings/0001584207-25-000025.md) | [22.1](/filings/0001584207-25-000038.md) | [22.3](/filings/0001584207-25-000046.md) | [22.7](/filings/0001584207-26-000020.md) | [22.4](/filings/0001584207-26-000020.md) |
| Shareholders' equity | $bn | [3.1](/filings/0001584207-24-000028.md) | [3.1](/filings/0001584207-24-000028.md) | [3.2](/filings/0001584207-26-000008.md) | [3.2](/filings/0001584207-25-000038.md) | [3.2](/filings/0001584207-25-000046.md) | [3.2](/filings/0001584207-25-000046.md) | [3.2](/filings/0001584207-26-000020.md) | [3.3](/filings/0001584207-26-000020.md) | [3.3](/filings/0001584207-25-000046.md) | [3.4](/filings/0001584207-25-000046.md) | [3.4](/filings/0001584207-26-000020.md) | [3.4](/filings/0001584207-26-000020.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [683 d](/filings/0001584207-24-000021.md) | [596 d](/filings/0001584207-24-000028.md) | [678 d](/filings/0001584207-26-000008.md) | [558](/filings/0001584207-25-000025.md) | [712 d](/filings/0001584207-25-000038.md) | [677 d](/filings/0001584207-25-000046.md) | [752 d](/filings/0001584207-26-000008.md) | [665](/filings/0001584207-26-000020.md) | [774 d](/filings/0001584207-25-000038.md) | [828 d](/filings/0001584207-25-000046.md) | [865 d](/filings/0001584207-26-000008.md) | [739](/filings/0001584207-26-000020.md) |
| Dividends paid | $m | [122 d](/filings/0001584207-24-000021.md) | [121 d](/filings/0001584207-24-000028.md) | [121 d](/filings/0001584207-26-000008.md) | [122](/filings/0001584207-25-000025.md) | [125 d](/filings/0001584207-25-000038.md) | [126 d](/filings/0001584207-25-000046.md) | [125 d](/filings/0001584207-26-000008.md) | [126](/filings/0001584207-26-000020.md) | [125 d](/filings/0001584207-25-000038.md) | [125 d](/filings/0001584207-25-000046.md) | [123 d](/filings/0001584207-26-000008.md) | [128](/filings/0001584207-26-000020.md) |
| Share repurchases | $m | [7.0 d](/filings/0001584207-24-000021.md) | [11.0 d](/filings/0001584207-24-000028.md) | [20.0 d](/filings/0001584207-26-000008.md) | [5.0](/filings/0001584207-25-000025.md) | [8.0 d](/filings/0001584207-25-000038.md) | [19.0 d](/filings/0001584207-25-000046.md) | [3.0 d](/filings/0001584207-26-000008.md) | [16.0](/filings/0001584207-26-000020.md) | [21.0 d](/filings/0001584207-25-000038.md) | [33.0 d](/filings/0001584207-25-000046.md) | [71.0 d](/filings/0001584207-26-000008.md) | [107](/filings/0001584207-26-000020.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [125](/filings/0001584207-23-000023.md) | [124](/filings/0001584207-23-000028.md) | [121](/filings/0001584207-24-000014.md) | [121](/filings/0001584207-24-000021.md) | [121](/filings/0001584207-24-000028.md) | [120](/filings/0001584207-25-000025.md) | [120](/filings/0001584207-25-000038.md) | [120](/filings/0001584207-25-000046.md) | [120](/filings/0001584207-26-000020.md) | [119](/filings/0001584207-25-000038.md) | [119](/filings/0001584207-25-000046.md) | [117](/filings/0001584207-26-000020.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 115,530,952 at 2026-04-21, from the cover of the [10-Q filed 2026-05-01](/filings/0001584207-26-000020.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.